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Abstract
Background: Inter-individual variation in normal human mammary epithelial cells in response to
oxythioquinox (OTQ) is reported. Gene expression signatures resulting from chemical exposures
are generally created from analysis of exposures in rat, mouse or other genetically similar animal
models, limiting information about inter-individual variations. This study focused on the effect of
inter-individual variation in gene expression signatures.
Methods:  Gene expression was studied in primary normal human mammary epithelial cells
(NHMECs) derived from four women undergoing reduction mammoplasty [Cooperative Human
Tissue Network (National Cancer Institute and National Disease Research Interchange)]. Gene
transcription in each cell strain was analyzed using high-density oligonucleotide DNA microarrays
(HuGeneFL, Affymetrix™) and changes in the expression of selected genes were verified by real-
time polymerase chain reaction at extended time points (ABI). DNA microarrays were hybridized
to materials prepared from total RNA that was collected after OTQ treatment for 15, 60 and 120
min. RNA was harvested from the vehicle control (DMSO) at 120 min. The gene expression profile
included all genes altered by at least a signal log ratio (SLR) of ± 0.6 and p value ≤ 0.05 in three of
four cell strains analyzed.
Results: RNA species were clustered in various patterns of expression highlighting genes with
altered expression in one or more of the cell strains, including metabolic enzymes and transcription
factors. Of the clustered RNA species, only 36 were found to be altered at one time point in three
or more of the cell strains analyzed (13 up-regulated, 23 down-regulated). Cluster analysis
examined the effects of OTQ on the cells with specific p53 polymorphisms. The two strains
expressing the major variant of p53 had 83 common genes altered (35 increased, 48 decreased) at
one or more time point by at least a 0.6 signal log ratio (SLR). The intermediate variant strains
showed 105 common genes altered (80 increased, 25 decreased) in both strains.
Conclusion: Differential changes in expression of these genes may yield biomarkers that provide
insight into inter-individual variation in cancer risk. Further, specific individual patterns of gene
expression may help to determine more susceptible populations.
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Background
Oxythioquinox (Morestan™ or OTQ, Bayer Corp) is a pro-
totypical pesticide that was first used in 1968 on crops
such as apples, pears, cucumbers, and gherkins. However,
its use was later confined to non-food crops, limiting
exposure to nursery and greenhouse employees. OTQ is a
member of the quinoxaline class of pesticides, which also
includes chlorquinox and thioquinox. Principal agricul-
tural use of OTQ was limited to the states of California,
Washington, Florida, New York, Pennsylvania, Ohio and
Michigan [1]. The use of OTQ in the United States was
voluntarily cancelled in 1999 with stocks in use until
2001, although OTQ is still listed in many different
regions for use as an insecticide [2,3]. Further, OTQ is still
in use today in other areas of the world, including Aus-
tralia and the Caribbean [4,5].
Scientifically acceptable toxicity studies of OTQ are
sparse. Early in vivo studies in rats found alterations of a
variety of metabolic enzymes following OTQ exposures,
including alkaline phosphatase [6]. Although not directly
analyzed, the results of this study combined with an ear-
lier study [7] suggest a direct effect of OTQ on succinate
dehydrogenase, or other enzymes with a thiol group. Fur-
ther work by Carlson et al (1970) [7] showed that,
although OTQ has a low acute toxicity, cumulative expo-
sure to this pesticide is not well-tolerated by exposed ani-
mals, with the majority of damage found in the liver of
these animals. Further studies looking mainly at hepatic
enzyme function found that OTQ exposure inhibits some
hepatic enzyme functions [8]. OTQ was shown to be a car-
cinogen and hepatotoxin in laboratory animals in later
studies [9]. OTQ has also been classified as a probable
human carcinogen [10]. However, potentially carcino-
genic exposures have already occurred and OTQ is still in
use outside of the US, its mechanism of action remains of
interest. In addition, OTQ has been shown to have an
inhibitory effect on cytochome P450s, enzymes known to
have a pivotal role in carcinogen metabolism [8,11-13].
Although early studies focused on hepatic effects, carcino-
genic potential may occur in other tissues as well. While
there have been multiple pesticides implicated in breast
cancer, no studies have been published related to OTQ
exposure and human cancer incidence [13].
This study is similar to work currently being carried out to
determine gene expression profiles of a variety of environ-
mental agents, including chemicals, physical agents and
physiologic stresses [14-19]. The National Institute of
Environmental Health Systems (NIEHS) has recently
funded a consortium to expand the study of gene expres-
sion profile signatures for various chemicals, with the
long-term goal to use these analyses in a validated gene
expression profile signature database. A recent report by
Shan etal. 2002 [20] is a good example of the differences
between gene expression profile signatures for two chem-
icals in an animal system. This report profiled gene expres-
sion in rat carcinomas induced by two carcinogens, 2-
amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP)
and 7,12-dimethylbenz [a]anthacene (DMBA), and was
able to show that while both chemicals altered expression
in some genes in a similar fashion, each induced unique
gene expression patterns.
The primary goal of this study was to look for consistent
changes common to all donors that could potentially be
used as biomarkers of exposure, creating a gene expres-
sion profile following OTQ exposure in normal human
cells. Given previous research in hepatoxicity, ideally nor-
mal human liver cells would have been used as a model
system. However, we needed a normal human tissue that
was readily accessible. Therefore, gene expression was
studied in primary normal human mammary epithelial
cells from four different donors in response to OTQ expo-
sure. Current microarray analysis of pesticide exposure
focuses on animal studies, not allowing for analysis of
inter-individual variation. With the use of microarrays
including clinical diagnosis, genetic susceptibility to dis-
ease and treatment, the need to determine the potential
role of inter-individual variation on gene expression pat-
terns in all potentially exposed tissues. Genes found to be
altered in multiple cell strains could be considered
biomarkers for individual populations. Given the small
number of cell strains used, follow-up analysis in a larger
number of samples is required to confirm any potential
biomarkers. Biomarkers derived from this study could
potentially be used in future epidemiology studies analyz-
ing the effects of pesticide exposure. Further, this gene
expression profile could be compared to those of other
pesticides and of known carcinogens to develop a more
detailed mechanistic definition of these chemicals.
Methods
Cell culture
Primary normal human mammary epithelial cells
(NHMECs) were derived from tissues salvaged at reduc-
tion mammoplasty obtained though the Cooperative
Human Tissue Network (National Cancer Institute and
National Disease Research Interchange). Development
and characterization of cell strains was achieved using
standard methods [21]. Cells were grown in MEGM media
(Clonetics, Cambrex, Pittsburgh, PA) at 37°C and 5%
CO2.
OTQ treatment
Treatment was performed on cells in passage six at 70%
confluency, as routinely performed in our laboratory. Pre-
liminary studies analyzed a range of OTQ concentrations
(0 – 12.5 µM) selected based on previous research [6,7]
and time points (0 – 24 hours), and showed maximumEnvironmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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effect of OTQ on p53 expression with minimal toxicity at
2 hours with a final concentration of 6.25 µM. Cells were
treated by diluting the stock OTQ/DMSO mixture in
media and adding this solution to aspirated cells, allow-
ing even exposure to all cells. DMSO (0.001%) alone was
used as a vehicle control. At the end of the treatment
period, cells were removed for RNA isolation. Cell viabil-
ity was determined by Trypan Blue exclusion assay.
Indirect immunofluorescence
Confluent cells in passage five were trypsinized and plated
on eight-well slides (LabTek II Slide System, Nunc, Naper-
ville, IL). These cells were grown to 70% confluency
before being treated with OTQ (6.25 µM) for 15, 60 and
120 min or DMSO (0.001%) for 120 min. At the end of
treatment, the media was aspirated and the cells were
fixed with methanol. Slides were then stained with anti-
p53 antibody (1:1000, DO-1, Santa Cruz Biotech, Santa
Cruz, CA) and incubated overnight at 4°C. The next day,
the media was again removed and the secondary antibody
(1:1500, goat anti-mouse FITC, Santa Cruz Biotech) was
incubated for one hour at room temperature. Slides were
washed in triplicate with phosphate buffered saline (PBS)
and cover slips were added. Slides were dried for one hour
at room temperature before viewing, using the laser scan-
ning confocal microscope BX50 (Olympus), and quanti-
tative analysis was performed [22]. Relative p53
expression was quantified between different time points
and strains by determination of the area under the inte-
grated intensity curve (Fluoview, Olympus, B & B Micro-
scopes, Pittsburgh, PA).
Microarray analysis
Microarray analysis was performed in duplicate using the
HuGeneFL high-density oligonucleotide microarrays
(Affymetrix™, Santa Clara, CA). Protocols from the
Affymetrix Expression Analysis Technical Manual were
followed
RNA was isolated from cells with Trizol (Gibco, Grand
Island, NY), followed by purification with RNEasy Mini
Kit (Qiagen, Valencia, CA). Spectrophotometer measure-
ments were required to give a 260/280 ratio of 1.9–2.1 for
use in microarray analysis. Double-stranded cDNA was
then synthesized from total RNA (Superscript Choice Sys-
tem, Invitrogen, Carlsbad, CA). An in vitro transcription
(IVT) reaction (Enzo, Farmingdale, NY) was then per-
formed to produce biotin-labelled cRNA from the cDNA.
Excess biotinylated dUTPs were removed by RNEasy Mini
Kit before being fragmented and added to a hybridization
cocktail, including Eukaryotic Hybridization controls
(Affymetrix), BSA and herring sperm DNA (Gibco, Grand
Island, NY) and biotinylated anti-streptavidin antibody
(Vector Laboratories, Burlingame, CA). Hybridization on
microarrays was performed for 16 hours at 45°C in the
Gene Chip Hybridization Oven with rocker (Affymetrix).
Microarrays were washed and stained using the protocol,
as described in the Affymetrix Manual, with the GeneChip
Fluidics Station 400 (Affymetrix). Arrays were then
scanned with the Affymetrix Scanner (Hewlett Packard,
Palo Alto, CA). Expression profiles were analyzed using
Microarray Suite 5.0, MicroDB 3.0 and Data Mining Tool
3.0 (Affymetrix). Affymetrix arrays are produced using
multiple 25-mer oligonucleotides (11–20 per target
gene). Each oligonucleotide is created to match the
selected region of the target gene (perfect match, PM),
while a similar oligonucleotide is created altered in the
13th position to control for non-specific binding (mis-
match, MM). Results are given in signal intensities with a
p-value determined from perfect match/mismatch (PM/
MM) intensities by Tukey's Biweight analysis. Each array
was normalized to a scaling factor of 1500 to correct for
array variation. All arrays for each cell strain were analyzed
on the same day to minimize variation.
Signal log ratio was determined by comparison of the sig-
nal intensities for the baseline (vehicle control) and the
treatment array. This is computed using a one-step Tukey's
Biweight method by taking a mean of the log ratios of
probe pair intensities across the two arrays. This method
helps to filter out differences due to different probe bind-
ing coefficients that may lead to false positives and/or
negatives. A signal log ratio of zero represents no change
in gene expression as a result of OTQ exposure. A signal
log ratio of one is equivalent to a fold change of two
between the treatment and control. The results described
here are the average of both duplicates, with the average
percent variability between duplicate arrays being 1.5%
(the average difference found between duplicates, related
to array to array variability as well as technical variability
in processing the array). Only relative changes equal to or
greater than 0.6 signal log ratio (SLR) were considered a
significant change as a result of exposure. The biological
significance of each change is determined with Wilcoxon's
signed rank test with the Affymetrix software. Gene chip
analysis was performed by self-organizing map (SOM)
clustering, focusing on genes with a detection p value of
0.05 or less at one or more time points. Analysis was per-
formed to comply with MIAME standards.
Real-time polymerase chain reaction analysis (RT-PCR)
cDNA synthesized from each sample as in the Affymetrix
analysis (Invitrogen) was used in a one-step RT-PCR anal-
ysis reaction. Analysis was performed in duplicate on the
ABI 7700 cycler, with the SYBR Green Master Mix (ABI)
and samples were normalized using both 18S and
GAPDH expression levels for each sample. Primers were
designed using Primer Express® (ABI) to yield uniqueEnvironmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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fragments for each gene under study. Reactions were set
up following recommended protocols using 100 pmol of
each primer (Sigma-Genosys) and approximately 60 ng
template per reaction. Reactions were performed in dupli-
cate for each sample for 40 cycles (95°C/15 sec denatur-
ing step; 60°C/1 min annealing/extension step). Fold
change was determined based on average cycle threshold
(CT) values for all duplicates and converted to signal log
ratio.
Results
Trypan blue exclusion test
Trypan Blue was used to analyze toxicity by measuring cell
viability for each cell strain for each treatment. The results
showed a range of viability from 92–97% at all time
points, except for the last time point in strain 3, which had
a viability of only 65% at 120 min (results not shown).
This decrease in viability at 120 min was not found to be
directly correlated to p53 or p21 protein expression, or to
any particular gene expression pattern. The dose of OTQ
used was based on these findings.
Indirect immunofluorescence
Baseline  p53  protein levels were visually compared to
those after treatment in each cell strain. Integrated fluores-
cence intensities were measured on each optical slice of
cells. The fluorescence was determined as the area under
the curve in arbitrary units (AU) (Figure 1). This result was
compared between time points for each cell strain. An
increase was seen in p53 expression in all cell strains with
increasing duration of an OTQ exposure. However, one
strain (3) showed a 10-fold lower p53 expression at each
time point.
DNA microarray
DNA microarray analysis found no change in p53, despite
the increase in p53 protein levels observed by immunoflu-
orescence. Studies of benzo [a]pyrene exposure in our
laboratory have also found similar results for p53 expres-
sion [23]. The effect of OTQ exposure on other cell cycle
genes, however, was determined by DNA microarray
analysis.
Although inter-individual variation between donors in
response to OTQ was evident, there were also some genes
found to be increased consistently in all strains by micro-
array analysis (Table 1). Self-organizing map (SOM) clus-
tering was used to group genes with similar patterns of
alteration in each of the strains. SOM analysis was per-
formed following filtering of the total genes on the array,
limiting the SOM analysis to only genes found to be
present on at least one array analyzed. Following sug-
gested analysis with the Affymetrix system, the default set-
tings of the Affymetrix software were selected, including
selecting threshold filtering (min = 20, max = 20000), row
variation filtering (max/min = 3 and max-min = 100), and
row normalization (mean = 0, variance = 1). Working
with a 3 × 3 analysis to obtain 9 clusters generally gave an
optimal amount of different clusters with less than 100
genes per cluster. From the SOM clustering analysis, genes
altered by a signal log ratio of ± 0.6 or greater were chosen
for closer study.
SOM clustering was used to show patterns of expression
in each cell strain, and followed by further subclustering
of those clusters of interest across all cell strains (Figure 2).
This analysis was performed with Data Mining Tool 3.0
(Affymetrix). For comparison to earlier versions of the
Affymetrix software, a signal log ratio of one is equal to a
fold change of two. SOM clustering led to the selection of
genes found to be altered, with the overall total of 215
genes (13 increased in 3 or more strains; 23 decreased in
3 or more strains). To be included, the genes must have a
signal log ratio of ± 0.6, which is approximately a 1.5 fold
change. Signal log ratio was used to linearize the data for
ease of analysis. The full list of genes altered can be found
at http://www.cdc.gov/niosh/ext-supp-mat/weston/
AlteredGenes.htm.
From the full list of genes that fit these criteria, selected
genes were chosen due to their potential role in carcino-
genesis, whether by cell cycle control, immune response
Quantitative analysis of immunofluorescence microscopy Figure 1
Quantitative analysis of immunofluorescence micros-
copy. Confocal microscopy analysis of p53 expression. Inte-
grated intensity measures were obtained from Fluoview and 
graphed with GraphPad Prism (GraphPad Software, San 
Diego, CA) to determine area under the curve as a measure 
of comparative p53 protein expression for each treatment 
time point. Data is shown for each time point per cell strain 
on the ordinate and the intensity on the abscissa (arbitrary 
units, AU). There was an increase in p53 protein expression 
for all of the strains tested in direct correlation with OTQ 
exposure. In one intermediate strain (3), p53 expression was 
10-fold lower at all time points.Environmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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or other specific functions. Functions were described as
annotated by NetAffx [24]. These genes are listed in Table
1. Some genes were selected based on their possible role
in disease as a result of pesticide exposure. Table 1 con-
tains 8 genes increased in at least three of the four cell
strains analyzed by 1.5 fold, as compared to the vehicle
control and a list of 5 genes decreased in three or more of
the four strains analyzed. Included in this list are two
genes involved in the metabolic activation of endogene-
ous chemicals, cytochrome P4502A13 (CYP2A13) and dihy-
drodiol dehydrogenase. Although expression was slightly
increased at one time point, the temporal patterns were
slightly different (Figures 3 and 4). This increase in all cell
strains suggests a potential role for these genes in OTQ
metabolism. These results are confirmed at these time
points as well as at 12 h and 24 h by RT-PCR (Table 2).
Genes also found to be increased in at least three of four
cell strains analyzed include genes involved in transcrip-
tion (junB,  cfos), immune response (cyclophilin), and
apoptosis (MAD-3). These genes showed a consistent
increase in expression following exposure to OTQ (Table
1). Genes that showed a consistent decrease in expression
following exposure include signalling pathway genes
(MAP kinase kinase), cell metabolism genes (S-adenosylme-
thionine synthetase, cytochrome bc-1), and transcription fac-
tors (E1A enhancer).
Some genes of interest were variably altered by strain,
examples of which are also listed in Table 1. These include
genes involved in carcinogenesis (raf oncogene, GADD45,
EWS, Cyclin D1) as well as immune response (immunophi-
Table 1: Genes altered following oxythioquinox exposure. Table represents data mined from HuGeneFL microarrays (Affymetrix). All 
genes selected have a signal log ratio of ± 0.6 unless otherwise noted. Representative genes for each group were selected based on their 
function and are shown here.
GenBank ID Name Peak Expression Level (SLR) Functional Class
Genes increased in three or more strains (n = 13):
U22028 CYP2A13 1.5 xenobiotic metabolism
U20734 junB 3.42 transcription
V01512 cfos 2.04 transcription
S85655 prohibitin 0.75 cell proliferation
S82240 RhoE GTPase 2.81 signal transduction
M69043 MAD-3 mRNA encoding IkB-like 
activity
0.83 apoptosis
M63573 cyclophilin 1.68 immune response
U05861 Dihydrodiol dehydrogenase 2.52 xenobiotic metabolism
Genes decreased in three or more strains (n = 23):
L05624 MAP Kinase Kinase -0.67 signal transduction
U18018 E1A enhancer -1.34 transcription
X56681 junD -1.03 transcription
X68836 S-adenosylmethionine synthetase -2.57 cell metabolism
J04973 Cytochrome bc-1 -3.12 cell metabolism
Genes altered in at least two of four cell strains (n = 189):
X03484 raf oncogene 1.46 carcinogenesis
M60974 growth arrest and DNA-damage-
inducible protein (gadd45)
1.51 DNA damage
M57731 Human gro-beta 1.85 immune response
X66899 EWS 1.2 carcinogenesis
Z29087* Cyclin D1 Promoter 1.03 cell cycle control
L10910 Splicing Factor CC1.3 0.62 RNA processing
M83667 NF-IL6 Permeability Factor 1.55 transcription
M27281 Vascular Permeability Factor -1.09 cell proliferation
L28010 HnRNP F protein -0.55 RNA processing
U72649 BTF2 -1.86 carcinogenesis
M19267 tropomyosin -1.16 cardiac
M38258 retinoic acid receptor gamma 1 -0.94 cell metabolism
U42031 Immunophilin -1.41 immune response
U67122 ubiquitin-related SUMO-1 -1.03 protein metabolism
X70340 Transforming growth factor alpha -0.57 cell proliferation
M34458 Lamin B -1.33 cell proliferation
*No accession number was used by Affymetrix. This accession number most closely matches the probe description and sequence.Environmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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lin, gro-β), cell proliferation (TGFβ), and RNA processing
(HnRNP F protein).
Real-time PCR
Real-time PCR was used to confirm and extend results
seen by microarray analysis for selected genes. Following
the original microarray analysis, patterns of some genes
appeared to be changing at the latest time point (120
min), so extended time points were selected (12 and 24 h)
to see a more complete expression profile for these genes.
Due to limited amount of cDNA, genes were analyzed at
15 min and/or 120 min, and then analyzed at 12 and 24
h by RT-PCR. Extended time points were selected to look
at specific genes found altered at the earlier time points.
These genes were selected due to their function and/or
pattern of expression, and determining their expression
pattern at later time points was of interest. Results are
shown in Table 2. In the majority of samples, RT-PCR
confirmed data found by microarray analysis for the genes
listed. Some discrepancies are also shown, however, in
these cases it is believed that the primer sequence is more
specific to the gene in question than the probe sequence
used on the array. However, extended time points, in
some cases, showed that the results of early time points
did not always continue to extended exposures. The RT-
PCR results for prohibitin, DDH, and CYP2A13 at 24 h
SOM clustering Figure 2
SOM clustering. Self-organizing map clustering groups' genes by similar expression patterns. Each data point represents an 
OTQ treatment time point. Data points are plotted in order of cell strain with four points per strain (DMSO, 15 min, 60 min, 
and 120 min). Levels of expression are not given, as patterns of expression are based on relative expression levels. Panels 4 and 
7 of this graph show genes increased at 15 minutes for one strain (3) follow similar pattern in second strain (4). Similar pattern 
is also seen in panels 6 and 8 of this graph.Environmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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showed a decrease in expression in some of the cell strains
analyzed. Samples not available for RT-PCR analysis are
listed as N/A in Table 2.
Discussion
The purpose of this study was to determine if microarray
analysis of four normal human mammary cell strains with
a known haplotype could be used to find biomarkers
related to either exposure in general or the specific haplo-
type in question. The use of only four cell strains was
determined to have enough power to provide basic infor-
mation to lead to further study if necessary. This study
would be followed up for specific genes of interest in a
larger number of cell strains, preferably bypassing the
more expensive and time-consuming microarray analysis
for RT-PCR only.
DNA microarray analysis was used to profile the cellular
response to OTQ, a quinoxaline pesticide. Analysis
revealed genes with common response across the four
human cell strains studied as well as inter-individual var-
iation in response. Using only four normal human cell
strains, our goal was to discover any distinctly altered
genes in response to OTQ exposure. Future analysis with
a larger number of cell strains will be used to follow-up
this analysis on specific genes of interest.
The majority of studies looking at gene expression profiles
have used animal models, limiting any knowledge
obtained to genetically similar organisms. Analysis with
normal human cell strains, like those described here, will
give more information on inter-individual variation in
response to various chemicals. This information will yield
clues to the metabolic pathways of the specific chemicals,
and this increased knowledge will aid in determining
potential hazards in the environment and the workplace.
Given the large number of pesticides in use today, further
examination of the effect of these chemicals on individu-
als is warranted.
Following exposure to OTQ, NHMECs showed alterations
in genes involved in a variety of functions. These included
xenobiotic metabolism, transcription, and DNA synthe-
sis. Genes altered as a result of OTQ exposure in all strains
analyzed included transcription factors like junB and cfos
(the AP1 complex). A number of genes involved in car-
cinogenesis were found altered after exposure to OTQ,
both induced and down-regulated. For example, prohibitin
expression is found to be up-regulated in most cell strains
after OTQ exposure, with similar expression patterns asso-
ciated with a decrease in cancer incidence [25].
Metabolism genes that were altered after OTQ exposure,
like cytochome P4502A13 (CYP2A13) and dihydrodiol dehy-
drogenase, are involved in xenobiotic metabolism. It has
Expression pattern for CYP2A13 Figure 3
Expression pattern for CYP2A13. DNA microarray 
analysis of NHMEC strains. Analysis was performed as 
described on HuGeneFL high-density oligonucleotide micro-
arrays (Affymetrix). Results are plotted as duration of expo-
sure vs signal log ratio (SLR). Signal log ratio is a measure of 
comparative expression of the treatment vs. vehicle control 
(0.001% DMSO). Signal log ratio of one is equal to a fold 
change of two. A SLR of 0.6 (Fold Change ~1.5) was the arbi-
trary limit of our analysis. All genes given an Absent call by 
analysis software are shown with a SLR of zero. Asterisks 
indicate a statistically significant variation in expression from 
the control level as measured by Tukey's Biweight analysis.
Expression pattern for dihydrodiol dehydrogenase Figure 4
Expression pattern for dihydrodiol dehydrogenase. 
DNA Microarray analysis of NHMEC strains. Analysis was 
performed as described on HuGeneFL high-density oligonu-
cleotide microarrays (Affymetrix). Results are plotted as 
duration of exposure vs signal log ratio (SLR). Signal log ratio 
is a measure of comparative expression of the treatment vs. 
vehicle control (0.001% DMSO). Signal log ratio of one is 
equal to a fold change of two. A SLR of 0.6 (Fold Change 
~1.5) was the arbitrary limit of our analysis. All genes given 
an Absent call by analysis software are shown with a SLR of 
zero. Asterisks indicate a statistically significant variation in 
expression from the control level as measured by Tukey's 
Biweight analysis.Environmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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been suggested that CYP2A13 is the main metabolic acti-
vator of 4-(methylnitrosamino)-1-(3-pyridyl)-1-
butanone (NNK), a tobacco-specific nitrosamine [26].
The increase of CYP2A13 begins to wane at the final time
point tested, suggesting this alteration to be somewhat
transient. This is an unusual expression pattern for a cyto-
chrome p450, as genes in this family tend to show a grad-
ual increase in induction, and an equally gradual decrease
in expression. Further analysis by RT-PCR showed that
this p450 was increased at later time points (12 h and 24
h, Table 2). Another metabolic enzyme affected by OTQ
exposure is dihydrodiol dehydrogenase. Dihydrodiol
dehydrogenase is known to participate in activation of
certain polycyclic aromatic hydrocarbons (PAHs), so its
increase in the intermediate variant after OTQ exposure
may result in an increase in PAH activation [27,28]. Alter-
ations of genes like this may suggest an indirect role for
OTQ in carcinogenesis. Of these two genes, only
CYP2A13 seems specific to exposure to OTQ. DDH has
been found to be increased following exposure to various
chemicals, including malathion, di-n-butyl phthalate, and
benzo [a]pyrene (Gwinn in preparation, 2004) [23,29].
Some of the early results at 15 min by microarray analysis
may have been a consequence of the stress of exposure,
regardless of the chemical. Extending analysis to later
times determined whether results seen at these early time
points were still valid after longer exposure to OTQ. RT-
Table 2: RT-PCR results. Table represents real-time PCR data from selected genes of interest. Time points used were 15 min, 120 min, 
12 h and 24 h where shown. Results shown are results of replicate analysis with duplicate samples. Samples not analyzed represented 
by N/A.
Strain Gene SLR 15 min SLR 120 min SLR 12 h SLR 24 h
1 BTF2 1.41 N/A 1.53 0.3
2 BTF2 -1.56 N/A -1.32 -1.74
3 BTF2 0.18 N/A -0.89 -16.61
4 BTF2 0.62 N/A -0.36 0.65
1 CYP2A13 5.58 6.01 3.84 10.6
2 CYP2A13 2.7 0.62 1.1 -0.6
3 CYP2A13 5.76 4.77 -0.6 -1.64
4 CYP2A13 5.45 1.1 0.33 -1.51
1 DDH 1.23 -0.67 1.75 1.47
2 DDH -0.47 -0.62 0.96 5.41
3 DDH 0.86 -3.47 2.01 -3.84
4 DDH 3.44 N/A 5.53 6.09
1 EWS -1.18 -1.84 0.69 -5.64
2 EWS -6.64 -0.4 1.32 1.54
3 EWS -0.42 -0.22 -1.79 -6.64
4 EWS N/A 2.92 0.78 0.86
1 GADD45 -0.09 -0.22 -1.32 -5.06
2 GADD45 -1.03 -1.69 -1.94 -1.32
3 GADD45 0.82 -2.32 -1.56 -4.32
4 GADD45 1.34 9.05 6.4 7.72
1 MAD-3 -0.71 N/A -0.15 -3.64
2 MAD-3 -1.89 N/A -1.06 -0.38
3 MAD-3 0.34 N/A -0.58 -6.64
4 MAD-3 4.4 N/A -4.38 0.51
1 PROHIBITIN 0.31 N/A -0.3 0.96
2 PROHIBITIN -0.6 N/A 0.3 -1.18
3 PROHIBITIN -1.06 N/A -1.94 -2.84
4 PROHIBITIN 2.3 N/A -1.09 0.92
1 RAF 0.01 -2.25 1.21 -5.64
2 RAF -1.51 -0.27 -1.43 -0.06
3 RAF 0.37 -3.84 -1.12 -7.67
4 RAF 1.33 7.57 4.8 7.22
1 RhoE 0.59 N/A -0.62 -0.71
2 RhoE 0.26 N/A -1.18 1.08
3 RhoE 1.55 N/A -0.94 -5.64
4 RhoE 2.35 N/A 1.06 2.05Environmental Health: A Global Access Science Source 2004, 3:9 http://www.ehjournal.net/content/3/1/9
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PCR results given in Table 2 show that in most cases, the
extended time points showed a continued trend of expres-
sion (whether increased or decreased), except in some cell
strains for DDH,  prohibitin, and MAD-3. These results
show a reverse of the early expression patterns at the later
time points. Real-time PCR is a more specific method of
analysis, as it only interrogates one gene at a time with
primers designed uniquely to that gene. Conflicts in
results between the two methods can generally be attrib-
uted to cross-reaction between probes designed for similar
genes on the array. Sequence differences between the
probes on the array and those used in RT-PCR may also
play role in these results. The RT-PCR primers were
selected specifically for the gene in question, while the
probes on the array may not have been. Genes with
sequence homology but with altered patterns of expres-
sion may not have been differentiated in the array analy-
sis, but would be with the RT-PCR analysis.
Inter-individual variation as a result of genetic polymor-
phisms in genes of interest would focus on specific at-risk
worker populations. For example, the four cell strains ana-
lyzed in this study have been genotyped for a variety of
genes, in particular those involved in cell cycle control
and xenobiotic metabolism. Two of the four cell strains
selected for analysis are heterozygote for the minor variant
haplotype of p53, a cell cycle control gene (cell strains 3
and 4). Although no biological mechanism for the role of
this variant in carcinogenesis has been defined, several
studies associating this haplotype with various cancers
support such role [30-35]. Analysis of genes altered in just
those strains expressing this variant, including three genes
involved in cell cycle control: raf oncogene (X03484), cyclin
D1 (Z29087), and BTF2 (U72649) may further support
an association between OTQ exposure, p53 variant status
and carcinogenesis [36-38]. Of these, p53 has been
reported to increase GADD45 transcription in response to
DNA damage, which is associated with an increase in cell
cycle arrest and DNA damage repair, while increased lev-
els of raf oncogene have been associated with lung carcino-
genesis [39-41].
Given the small number of cell strains used, this analysis
needs to be extended to additional cell strains to deter-
mine the role of the p53 variants in gene expression differ-
ences. Due to the expense of microarray analysis, this is
performed in only a limited number of cell strains (4),
and selected genes will be further analyzed with |RT-PCR
in a larger number of cell strains. Over 80 cell strains have
been established in our laboratory to date, with half of
these having been genotyped for p53. However, given that
this haplotype is found only in a limited portion of the
population, this varied pattern of expression in key genes
in cell cycle control may highlight a specific at-risk
population.
Searches for similar natural compounds to replace these
potentially disruptive chemicals can also use gene expres-
sion profiles [42]. Profile comparisons to that of a natural
pesticide may decrease the need for organophosphates.
Comparison of OTQ's gene expression profile to that of
well-defined chemicals, like benzo [a]pyrene, will yield
important information about OTQ's role in both genoto-
xicity and potential carcinogenicity. A comparison
between many expression profiles is needed to further
define similarities and differences between this pesticide
and known carcinogens and/or other pesticides.
Conclusions
The overall goal of this project was to create a gene expres-
sion profile for OTQ or related pesticide analogues with
the hopes of finding genes to be used as potential biomar-
kers of exposure. This expression profile may also be used
to determine the final role of OTQ in carcinogenesis by
comparing it to profiles of known carcinogens. It is possi-
ble that the main effect of OTQ exposure is not on the
direct alterations in many genes, but on alterations in
genes potentially involved in carcinogenesis, among them
the examples of CYP2A13 and dihydrodiol dehydrogenase.
The results shown here do not suggest a direct role of OTQ
in carcinogenesis. They do, however, suggest OTQ expo-
sure leads to an increase in expression of genes that do
play a direct role in carcinogen; metabolism (for example,
exposure to carcinogens like NNK and benzo [a]pyrene
along with exposure to OTQ may lead to an increased
incidence of tobacco-related cancer) [27,43].
Discovery of genes altered following exposure to OTQ in
human cell strains may aid in future epidemiology studies
on pesticide exposures. Gene expression profiling can be
used to yield genetic biomarkers of exposure that, after
validation, could be used in a clinical setting for early
determination of organophosphate exposure, increasing
early treatment of pesticide illness and thereby increasing
the recovery rate of exposed individuals.
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